FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/02/017517 [Registered on: 07/02/2019] Trial Registered Prospectively
Last Modified On: 06/02/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical trial to study the effect of Trayushnadi guggulu and virechan karma in sthaulya. 
Scientific Title of Study   Management of Sthaulya (Obesity) with Trayushnadi Guggulu along with and without prior Virechana- An open labelled randomized comparative clinical trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vibhutikumari M Chaudhari 
Designation  Pg Scholar 
Affiliation  Govt Akhandanand Ayurved college Bhadra Ahmedabad 
Address  Room no 11 Panchkarma Department Govt Akhandanand Ayurved college Bhadra Ahmedabad

Ahmadabad
GUJARAT
380001
India 
Phone  9737323971  
Fax    
Email  vib1393@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sweety Ruparel 
Designation  Professor 
Affiliation  Govt Akhandanand Ayurved college Bhadra Ahmedabad 
Address  Room no 11 Panchkarma Department Govt Akhandanand Ayurved college Bhadra Ahmedabad

Ahmadabad
GUJARAT
380001
India 
Phone  9429202048  
Fax    
Email  sweetyruparel@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vibhutikumari M Chaudhari 
Designation  Pg scholar 
Affiliation  Govt Akhandanand Ayurved college Bhadra Ahmedabad 
Address  Room no 11 Panchkarma Department Govt Akhandanand Ayurved college Bhadra Ahmedabad

Ahmadabad
GUJARAT
380001
India 
Phone  9737323971  
Fax    
Email  vib1393@gmail.com  
 
Source of Monetary or Material Support  
Room no 11 Panchkarma Department Govt Akhandanand Ayurved college Bhadra Ahmedabad 
 
Primary Sponsor  
Name  Govt Akhandanand Ayurved college  
Address  Govt Akhandanand Ayurved college Bhadra Ahmedabad 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vibhutikumari M Chaudhari  Govt Akhandanand Ayurved College  Room no 11 Panchkarma department Govt Akhandanad Ayurved College Ahmedabad
Ahmadabad
GUJARAT 
9737323971

vib1393@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E669||Obesity, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Trayushnadi guggulu  Trayushnadi guggulu will be prepared as described in Sharangdhar Samhita (GugguluKalpana) Dose 12 gm in a day in tablet form in three divided doses (each tablet 500 mg) With Ushnodaka for 8 weeks 
Comparator Agent  VirechanaPoorvakShamana(Trayushandi guggulu)  Shodhana Virechan Karma is divided into 3 parts PurvaKarma Deepana andPachana Drug TrikatuChurna Dose 4 to 6 gm per day 2 to 3 gm twise a dayas per Aatur-Agni Duration3 to 5 days till lakshana of Agnidipti appeared Aabhyantar Snehpan Sneha dravya Trayushnadi Ghrit Dose 20 to 40 ml starting dose in Vardhmana Krama As perAatur-Koshtha and Agni Time Naishejirne Duration 3 to 7 days depending upon the Samyak-Snigdha Lakshana Anupan Ushnodak Diet Light diet Drav Ushana Annaabhishyandi Pramanatha Natisnighdha Asnkrina Abhyanga and Swedana Time After completion of Abhyantara Snehapana 1st day and 2nd day during Vishrama Kala 3rd day – Prior to Virechana Karma Diet drav ushna Pittavrudhdhikar will be given in the dinner at previous night of Virechan Karma Pradhan karma Virechana Karma with Trivrut Varadi Yoga dose 40-60 gm At Shleshma Kale Gate with Ushnodak after virechana karma Samsarjana Karma will be advised according to shudhdhi 3 5 or 7 days for shamana treatment trayushnadi guggulu will be given for 8 week 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  classical signs & symptoms of Sthaulya (Javoparadh, Kriccha Vyavayta, Daurbalya, Daurgandhya, Swedabadh, Atikshudha, Atipipasa)
BMI (Body Mass Index) ≥ 25 and ≤ 35
In Shodhana group Virechy 
 
ExclusionCriteria 
Details  Patients suffering from Pulmonary diseases, Cardiac diseases, Hypothyroidism, Hypertension, PCOD, HIV Patients having B.M.I. more than 35
In Shodhana group Avirechya
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Result will be assessed on the basis of sign and
symptoms of Sthaulya and By observing BMI Body Circumference
 
8 Weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
Result will be assessed on the basis of changes in cholesterol triglycerides LDL HDL and VLDL values from baseline   8 Weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/02/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   To study the effect of Trayushnadi guggulu with Virechana karma and without Virechana karma in the management of Sthaulya obesity this study is randomized open label parallel group trial 
Close